OA02.05 CK-101 (RX518), a Third Generation Mutant-Selective Inhibitor of EGFR in NSCLC: Results of an Ongoing Phase I/II TrialM. Johnson, J. Karlix,H. Burris,S. Jones,D. Harris,K. O'Byrne, V. Sriuranpong,C. Charoentum, N. Prasongsook, W. Jitpewngam, K. Wirasorn,J. Wang,S. Waqar, J. Oliviero,L. Gorelik, X. QianJOURNAL OF THORACIC ONCOLOGY（2018）引用 4|浏览13暂无评分关键词EGFR,NSCLC,T790MAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
